线粒体自噬在脓毒症中的研究进展
张欣桐1 刘景卓1 李盼1 马德胜1 马莉2
1.兰州大学第二临床医学院,甘肃兰州 730030;
2.兰州大学第二医院重症医学科三病区,甘肃兰州 730030
Research progress of mitophagy in sepsis
ZHANG Xintong1 LIU Jingzhuo1 LI Pan1 MA Desheng1 MA Li2
1.The Second Clinical Medical College, Lanzhou University, Gansu Province, Lanzhou 730030, China;
2.Department of Intensive Care Unit Three, Lanzhou University Second Hospital, Gansu Province, Lanzhou 730030, China
摘要 脓毒症是重症监护病房的常见疾病,具有高发病率、高死亡率的特点,易发生全身多器官损伤甚至衰竭。当前,脓毒症的治疗以病因治疗、液体复苏、抗感染等目标为主,由于病情进展迅速导致治疗效果欠佳。线粒体自噬可通过Parkin依赖性途径和Parkin非依赖性途径清除受损、老化和功能障碍的线粒体,有效避免细胞过度损伤,维持细胞内环境稳态,在许多疾病中发挥重要作用。线粒体自噬在Parkin、Fun14结构相关蛋白1、Bcl-2相互作用蛋白3、线粒体动力学相关蛋白1介导下能够抑制炎症因子和活性氧的释放,减少多器官功能障碍的发生,其在脓毒症中发挥保护作用。本文对线粒体自噬在脓毒症中的作用机制和治疗方面进行综述,旨在为脓毒症的治疗提供新的依据。
关键词 :
线粒体自噬 ,
脓毒症 ,
Parkin ,
多器官功能障碍 ,
治疗
Abstract :Sepsis is a common disease in intensive care unit, which is characterized by high morbidity and mortality, and is easy to cause systemic multiple organ damage and even failure. At present, the treatment of sepsis mainly focuses on etiological treatment, fluid resuscitation, anti-infection and other targets, but the treatment effect is not good due to the rapid progress of the disease. Mitophagy can clear damaged, aged and dysfunctional mitochondria through Parkin-dependent and Parkin-independent pathways, effectively avoid excessive cell damage and maintain homeostasis of intracellular environment, which plays an important role in many diseases. Mitophagy, mediated by Parkin, Fun14 domain-containing protein 1, Bcl-2 interacting protein 3, dynamin related protein 1, can inhibit the release of inflammatory factors and reactive oxygen species, reduce the occurrence of multiple organ dysfunction, and play a protective role in sepsis. This article reviews the aspects of the mechanism and treatment of mitophagy in sepsis, so as to provide a new basis for the treatment of sepsis.
Key words :
Mitophagy
Sepsis
Parkin
Multiple organ dysfunction
Therapy
基金资助: 国家临床重点专科建设项目(甘财社〔2014〕20号)。
通讯作者:
马莉(1970-),女,博士,硕士生导师,主任医师,兰州大学第二医院重症医学科三病区主任;研究方向:脓毒症的基础和临床研究。
作者简介 : 张欣桐(1994-),女,兰州大学第二临床医学院2018级急诊医学专业在读硕士研究生;研究方向:脓毒症等急危重症。
[1] Singer M,Deutschman CS,Seymour CW,et al. The Third International Consensus Definitions for Sepsis and Septic Shock(Sepsis-3) [J]. JAMA,2016,315(8):801-810.
[2] Kumar S,Tripathy S,Jyoti A,et al. Recent advances in biosensors for diagnosis and detection of sepsis:A comprehensive review [J]. Biosens Bioelectron,2019,124/125:205-215.
[3] Kim MJ,Yoon JH,Ryu JH. Mitophagy:a balance regulator of NLRP3 inflammasome activation [J]. BMB Rep,2016, 49(10):529-535.
[4] Chen H,Mao X,Meng X,et al. Hydrogen alleviates mitocho- ndrial dysfunction and organ damage via autophagy mediated NLRP3 inflammasome inactivation in sepsis [J]. Int J Mol Med,2019,44(4):1309-1324.
[5] Wang Y,Zhu J,Liu Z,et al. The PINK1/PARK2/optineurin pathway of mitophagy is activated for protection in septic acute kidney injury [J]. Redox Biol,2020,38:101767.
[6] 江木秀.线粒体自噬对脓毒症心肌的影响及信号转导途径研究进展[J].国际儿科学杂志,2020,47(7):477-480.
[7] Galluzzi L,Baehrecke EH,Ballabio A,et al. Molecular definitions of autophagy and related processes [J]. EMBO J,2017,36(13):1811-1836.
[8] Rogov V,D?觟tsch V,Johansen T,et al. Interactions between autophagy receptors and ubiquitin-like proteins form the molecular basis for selective autophagy [J]. Mol Cell,2014, 53(2):167-178.
[9] Duann P,Lianos EA,Ma J,et al. Autophagy,Innate immunity and tissue repair in acute kidney injury [J]. Int J Mol Sci,2016,17(5):662.
[10] Lemasters JJ. Selective mitochondrial autophagy,or mitophagy,as a targeted defense against oxidative stress,mitochondrial dysfunction,and aging [J]. Rejuvenation Res,2005,8(1):3-5.
[11] Montava-Garriga L,Ganley IG. Outstanding questions in mitophagy:what we do and do not know [J]. J Mol Biol,2020,432(1):206-230.
[12] Rodger CE,McWilliams TG,Ganley IG. Mammalian mitophagy - from in vitro molecules to in vivo models [J]. FEBS J,2018,285(7):1185-1202.
[13] Huang J,Zhu T,Rong R,et al. FUN14 domain-containing 1-mediated mitophagy suppresses interleukin-1β production in macrophages [J]. Int Immunopharmacol,2020,88:106964.
[14] Xu Y,Tang Y,Lu J,et al. PINK1-mediated mitophagy protects against hepatic ischemia/reperfusion injury by restraining NLRP3 inflammasome activation [J]. Free Radic Biol Med,2020,160:871-886.
[15] Dai XG,Xu W,Li T,et al. Involvement of phosphatase and tensin homolog-induced putative kinase 1-Parkin-mediated mitophagy in septic acute kidney injury [J]. Chin Med J(Engl),2019,132(19):2340-2347.
[16] Nguyen TN,Padman BS,Lazarou M. Deciphering the molecular signals of PINK1/Parkin mitophagy [J]. Trends Cell Biol,2016,26(10):733-744.
[17] Zhang Z,Chen Z,Liu R,et al. Bcl-2 proteins regulate mitophagy in lipopolysaccharide-induced acute lung injury via PINK1/Parkin signaling pathway [J]. Oxid Med Cell Longev,2020,2020:6579696.
[18] Kang R,Zeng L,Xie Y,et al. A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis [J]. Autophagy,2016,12(12):2374-2385.
[19] Chen Z,Liu L,Cheng Q,et al. Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy [J]. EMBO Rep,2017,18(3):495-509.
[20] Wu W,Li W,Chen H,et al. FUNDC1 is a novel mitochondrial-associated-membrane (MAM) protein required for hypoxia-induced mitochondrial fission and mito-phagy [J]. Autophagy,2016,12(9):1675-1676.
[21] 闫梦莹,王妍妍,毛幸,等.脓毒症小鼠肝损伤时FUNDC1/LC3 Ⅱ信号通路的变化[J].中华麻醉学杂志,2018,38(6):736-738.
[22] Yan M,Yu Y,Mao X,et al. Hydrogen gas inhalation attenuates sepsis-induced liver injury in a FUNDC1-dependent manner [J]. Int Immunopharmacol,2019,71:61-67.
[23] Zhang T,Xue L,Li L,et al. BNIP3 Protein Suppresses PINK1 Kinase Proteolytic Cleavage to Promote Mitophagy [J]. J Biol Chem,2016,291(41):21616-21629.
[24] Leduc-Gaudet JP,Mayaki D,Reynaud O,et al. Parkin overexpression attenuates sepsis-induced muscle wasting [J]. Cells,2020,9(6):1454.
[25] Tong M,Zablocki D,Sadoshima J. The role of Drp1 in mitophagy and cell death in the heart [J]. J Mol Cell Cardiol,2020,142:138-145.
[26] 陈祝桂,彭志勇,张智豪,等.不同浓度脂多糖对脓毒症急性肺损伤肺上皮细胞坏死性凋亡和线粒体自噬的影响[J].中华实用诊断与治疗杂志,2020,34(4):330-333.
[27] Patoli D,Mignotte F,Deckert V,et al. Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis [J]. J Clin Invest,2020,130(11):5858-5874.
[28] Wang Y,Mao X,Chen H,et al. Dexmedetomidine alleviates LPS-induced apoptosis and inflammation in mac-rophages by eliminating damaged mitochondria via PINK1 mediated mitophagy [J]. Int Immunopharmacol,2019,73:471-481.
[29] Zhang E,Zhao X,Zhang L,et al. Minocycline promotes cardiomyocyte mitochondrial autophagy and cardiomyocyte autophagy to prevent sepsis-induced cardiac dysfunction by Akt/mTOR signaling [J]. Apoptosis,2019,24(3/4):369-381.
[30] Li J,Shi W,Zhang J,et al. To Explore the Protective Mechanism of PTEN-Induced Kinase 1(PINK1)/Parkin Mitophagy-Mediated Extract of Periplaneta Americana on Lipopolysaccharide-Induced Cardiomyocyte Injury [J]. Med Sci Monit,2019,25:1383-1391.
[31] Essandoh K,Wang X,Huang W,et al. Tumor susceptibility gene 101 ameliorates endotoxin-induced cardiac dysfunction by enhancing Parkin-mediated mitophagy [J]. J Biol Chem,2019,294(48):18057-18068.
[32] 李伟文,蓝秀,黎媛,等.丹酚酸A对脂多糖诱导人肺微血管内皮细胞线粒体自噬和细胞损伤的影响[J].温州医科大学学报,2018,48(4):267-270.
[33] Zhu J,Zhang S,Geng Y,et al. Transient receptor potential ankyrin 1 protects against sepsis-induced kidney injury by modulating mitochondrial biogenesis and mitophagy [J]. Am J Transl Res,2018,10(12):4163-4172.
[1]
王鑫源 赵兴申 刘瑾 余擎 程小刚. 牙周牙髓联合病变诊治的研究进展 [J]. 中国医药导报, 2021, 18(9): 35-38.
[2]
刘娣1,2 郑喆文1,2 张淑园1,2 朱春梅1,2 张红艳2 周云峰2. 乳腺癌放射治疗相关皮肤毒性研究进展 [J]. 中国医药导报, 2021, 18(9): 39-42.
[3]
戴锴 张倩 施金枝 陈晓蓓 龚作炯. CPPT教学中传染病学课程改革出现的问题及对策分析 [J]. 中国医药导报, 2021, 18(7): 59-62.
[4]
党志博1,2 晏军3 李玲孺4 李玲1,2 周怡驰1,2 胡世平2. 基于虚毒瘀理论探讨原发性肝癌的治疗 [J]. 中国医药导报, 2021, 18(7): 126-129.
[5]
王玲1 邱志敏2 陈婧1▲. 疼痛治疗仪联合综合护理干预对晚期中重度癌痛患者的疗效研究 [J]. 中国医药导报, 2021, 18(7): 169-172.
[6]
刘曙东 李文艳▲. 急诊血管内治疗CTA阴性大血管闭塞性急性脑梗死1例报告 [J]. 中国医药导报, 2021, 18(6): 177-180.
[7]
陈思玮 厉英超. 消化道第三空间的诊治进展 [J]. 中国医药导报, 2021, 18(5): 37-40.
[8]
刘铭兰1 肖黎明1 施尉红2. L-T4替代治疗妊娠合并SCH患者的临床效果及有效剂量 [J]. 中国医药导报, 2021, 18(5): 80-83.
[9]
师昉1 李福亮1 吕泽平2. 核心肌力训练结合脉动治疗仪治疗腰肌筋膜炎的效果 [J]. 中国医药导报, 2021, 18(5): 117-120.
[10]
林小飞1 顾小海1 于春琳1 朱红利1 吴云朵1 张军1 王玉美2. 儿童脓毒症的诊断进展 [J]. 中国医药导报, 2021, 18(4): 45-48,60.
[11]
史湖波1 徐祎慧2. 非小细胞肺癌新辅助治疗的进展 [J]. 中国医药导报, 2021, 18(3): 43-47.
[12]
杨琳丽1 王转1 叶霈智2. 透穴针刺法联合中药治疗恶性肿瘤放化疗后顽固性呃逆的临床观察 [J]. 中国医药导报, 2021, 18(2): 135-138.
[13]
章益琴1 章天天2 李晶2. 支持性心理治疗对慢性乙型肝炎患者自我感受负担及健康相关行为的影响 [J]. 中国医药导报, 2021, 18(2): 172-175.
[14]
陈巧 李玲 李素云. 脂肪肝营养治疗的研究进展 [J]. 中国医药导报, 2021, 18(12): 49-52.
[15]
贾晨1 潘华洋1 霍晓燕2 孟庆辉1. 直肠前突的治疗新进展 [J]. 中国医药导报, 2021, 18(12): 45-48,56.